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Abstract The role of the propeptide sequence and a disulfide 
bridge between sites 1 and 122 in chymotrypsin has been exam- 
ined by comparing enzyme activities of wild-type and mutant 
enzymes. The kinetic constants of mutants devoid of the Cysl- 
Cys122 disulfide-linked propeptide show that this linkage is not 
important either for activity or substrate specificity. However this 
linkage appears to be the major factor in keeping the zymogen 
stable against non-specific activation. A comparison of zymogen 
stabilities showed that the trypsinogen propeptide is ten times 
more effective than the chymotrypsinogen propeptide in prevent- 
ing non-specific zymogen activation during heterologous expres- 
sion and secretion from yeast. This feature can also be transferred 
in trans to chymotrypsinogen; i.e. the chymotrypsin trypsin 
propeptide chimera forms a stable zymogen. 
Key words: Zymogen activation; Chymotrypsin; Disulfide 
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1. Introduction 
Chymotrypsin and trypsin, the two pancreatic serine pro- 
teases in the intestine, are closely related both structurally and 
functionally. The vertebrate trypsins and chymotrypsins are 
45% identical in their amino acid sequence, and their tertiary 
structures are also very similar [l]. However, the propeptide 
segment of zymogens is not conserved in either amino acid 
sequence or structure. 
Besides length there are other characteristic differences be- 
tween the propeptides: The shorter trypsinogen propeptide has 
a distinctive structure characterized by four consecutive aspar- 
tate residues directly preceding the Lysl5-Ile16 peptide bond 
that is cleaved during activation [2,3]. The trypsinogen propep- 
tide is mobile, and projects into the solvent [MS], while the 
chymotrypsinogen propeptide is covalently linked to the 
Serl09-Ala132 loop via the Cysl-Cys122 disulfide bridge and 
several H-bonding interactions [7-91. Due to this disulfide 
bond, the chymotrypsinogen propeptide remains bound to the 
enzyme after activation. In contrast, the trypsinogen propep- 
tide dissociates from the enzyme. 
The characteristic four aspartic acids in the trypsinogen 
propeptide are a crucial component of the (Asp)4Lys recogni- 
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tion sequence of enterokinase, the specific enzyme that acti- 
vates trypsinogen. In constrast, chymotrypsinogen is activated 
by trypsin. 
The significance of the chymotrypsin(ogen)-specific Cysl- 
Cys122 disulfide, if any, is unknown. The Cysl-Cysl22 disul- 
fide could link the propeptide to the protein after activation 
perhaps because it displays a unique function in enzyme activity 
and/or specificity. Alternatively it may have a role in zymogen 
folding. To test these possibilities we constructed mutants in 
which the disulfide bond was eliminated. We also examined the 
relative abilities of the trypsinogen and chymotrypsinogen 
propeptides in preventing non-specific activation of the zymo- 
gens chimera in a yeast expression system by comparing the 
yields and stabilities of wild-type zymogens and a chymotrypsin 
trypsin propeptide chimera. 
2. Materials and methods 
2.1. Materials 
Restriction endonucleases, T4 polymerase and T4 ligase were from 
New England Biolabs or Boehringer. TSK Toyopearl SP-650M was 
bought from Supelco. High purity enterokinase was purchased from 
Biozyme. TPCK treated bovine trypsin for chymotrypsinogen activa- 
tion, SBTI Sepharose, MUGB, MUTMAC, succinyl-AlaAlaProPhe- 
pNA, 1 -Tyr-pNA and Bz- 1 -Lys-pNA amide substrates were the prod- 
ucts of Sigma Chemical Co. The tetrapeptide amide substrates, suc- 
cinyl-AlaAlaPro-Xaa-AMC were synthesized as described previously 
UOI. 
2.2. Cloning, mutagenesis and expression 
Rat enzymes were used throughout this study (type II for trypsin). 
The cloning of rat trypsinogen was described previously [l 11. The clon- 
ing of rat chymotrypsinogen was performed as follows. A lambda gtl I 
cDNA library of the rat cell line, AR425 was amplified by polymerase 
chain reaction using two oligonucleotides corresponding to the 5’ and 
3’ ends of the chymotrypsinogen coding region. The oligonucleotides 
used, SGCCACCCAAGCTTGTGGAGTCCCT3 and S’GCGAGC- 
TCAGGTGTCTTCCAAGAT3’ added a Hind111 site to the 5’ end and 
a Sac1 site to the 3’ end. 
The chymotrypsinogen mutants were constructed according to the 
Kunkel method [12] using ohgonucleotide SGGCCAGTGCCAAG- 
CTTCTGGAGTCCCT3’ for the CyslSer substitution and ohgonucle- 
otide 5’ACTGTGTCTGCCGTAT/GCTCTACCCAACGTCGAT3’ 
for the Cysl22AlalSer substitution. The mutations were verified by 
DNA sequencing [13]. The enzymes were expressed in the yeast system 
described for carboxypeptidase [14] as cc-factor leader peptide zymogen 
fusion proteins. (The a-factor leader peptide directs the protein into the 
culture medium and it is cleaved during the export.) The S’CTC- 
TCGACAAACGGATCGTCAACGGAGAGGATCCTATTC3’ and 
S’GGCAA-TAGCATCCTCTCCGTTGACGATCCGTTTGTCGAG- 
AGGTAC3’ oligonucleotides were used to form an d-factor leader 
peptide-chymotrypsinogen fusion protein by linking an XmaI site, 
created in chymotrypsinogen at the Pro24 and Gly25 triplets, to the 
KpnI site in the a-factor leader peptide. For another fusion construction 
ohgonucleotides 5’AGCTTTCdCGGTGGATGATGATGATAAGA- 
TCGTCAACGGAGAGGATGCTATTC3’ and S’CCGGGAATAG- 
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CATCCTCTCCGTTGACGATCTTATCATCATCATCCACCGGG- 
AA3’ were used to link the XmaI site in chymotrypsin to the Hind111 
site at the junction of &factor leader peptide and trypsinogen propep- 
tide. This construct encoded a chymotrypsin trypsin propeptide chi- 
mera that is fused to the a-factor leader peptide and contains a 
Cysl22Ser substitution. 
The level of protein expression was checked by SDS polyacrylamide 
gel electrophoresis performed in the absence of reducing agents. 500 ,uI 
supernatant of cultures of similar cell density were precipitated for 30 
min on ice by the addition of 1 ml of absolute ethanol. The precipitates 
were sedimented for 15 min, dried in vacua and resuspended in 50 ,uI 
sample buffer. After heating on 100°C for 3 min, 15 ~1 samples were 
loaded onto 12.5% polyacrylamide gels. 
2.3. Enzyme purification 
When the yeast culture media contained zymogens, they were iso- 
lated in inactive form on a TSK Toyopearl SP650-M cation exchanger 
[15], then they were activated at 37°C with an overnight enterokinase 
treatment (at 20 unit enterokinase/l.O mg zymogen ratio) or with a 
six-hour TPCK bovine trypsin treatment (at a 2 fig trypsU.0 mg 
zymogen ratio). After activation the activator trypsin was removed 
from the solution of the activated chymotrypsin (mutant) on a Ben- 
zamidine-Sepharose column. The active forms were purified by SBTI 
Sepharose affinity chromatography. In cases when the active forms of 
the enzymes rather than the zymogens were present in the culture 
media, they were purified by directly subjecting the cation exchange 
chromatography fractions to an SBTI Sepharose affinity column. The 
enzyme concentrations of trypsin and chymotrypsin were determined 
with”active site titration [16] by using active site titrants MUGB and 
MUTMAC, respectively. 
2.4. Enzyme assays 
The enzyme activities were determined on amide substrates at 37°C 
with photometry (p-nitroanilide liberation followed by the absorbancy 
at 410 nm) and fluorimetry (7-amino-4-methylcoumarin liberation, fol- 
lowed by the emission at 460 nm with excitation at 380 nm) in a 50 mM 
HEPES, 10 mM CaCl,, 0.1 M NaCl buffer (pH 8.0). The data were 
analyzed with the KinetAsyst software. For the determination of the 
active enzyme concentration in the culture medium, 100 ,~l aliquots of 
appropriately diluted culture medium were added to 70 ,~l of 500 mM 
HEPES, 100 mM CaCl,, 1 .O M NaCl buffer (pH 8.0), 520 ,~l water and 
10 ~1 of a 10 mM succinyl-AlaAlaProPhe-pNA (chymotrypsin sub- 
strate) or Bz-1-Lys-pNA (trypsin substrate) solution. The hydrolysis 
rates were measured on 410 nm. The total enzyme concentrations were 
determined in the same way after the activation of the zymogen forms. 
To this end 300 ,~l aliquots of the culture medium were treated with 1 .O 
pg TPCK bovine trypsin or 10.0 units enterokinase. Five minutes at 
37°C for trypsinogen activation and 10 minutes on ice for chymotryp- 
sinogen activation were sufficient to achieve maximal rates of substrate 
hydrolysis. 
3. Results 
To explore the structural and functional significance of disul- 
fide bond Cysl-Cys122 present in the chymotrypsin/ogen but 
not in trypsin/ogen structure (Fig. I), chymotrypsinogen mu- 
tants Cys 1 Ser-Cys 122Ala and Cys 1 Ser-Cys 122Ser, wild-type 
chymotrypsinogen, the chymotrypsin trypsin propeptide chi- 
mera chymotrypsinogen and wild-type trypsinogen were ex- 
pressed in yeast. The resulting culture media were compared by 
SDS polyacrylamide gel electrophoresis under non-reducing 
conditions (Fig. 2), and by measuring their enzyme activities 
before and after activation of the zymogens produced (Table 
1). The gel patterns of the yeast culture media indicated a high 
expression level for the chymotrypsin trypsin propeptide chi- 
mera chymotrypsinogen and wild-type trypsinogen (lanes 5 and 
6 in Fig. 2), while the expression of the other three protein 
constructs, especially those of the two chymotrypsinogen mu- 
tants without disulfide bridge Cysl-Cysl22 (lanes 2-3 in Fig. 
2) appeared to be relatively low. Concerning the electrophoretic 
Cow chymotrypsinogen A tiGVPAIQPVkGLSRiv 
Cow chymotrypsinogen B CGVPAIQPVLSGLARiv 
Dog chymotrypsinogen CGVPAIQPVLSGLSRiv 
Rat chymotrypsinogen CGVPTIQPVLTGLSRiv 
Rat trypsinogen II FPVDDDDKiv 
Cow trypsinogen VDDDDKiv 
Goat trypsinogen CDDDDKiv 
Sheep trypsinogen FPVDDDDKiv 
Pig trypsinogen FPTDDDDRiv 
Horse trypsinogen SSTDDDDRiv 
Dogfish trypsinogen APDDDDKiv 
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Fig. 1. Trypsinogen and chymotrypsinogen N-terminal sequences. The 
propeptide sequences are in capital letters, and the amino acids are bold 
between which the peptide bond is cleaved during activation. 
patterns it has to be reminded that electrophoretic mobilities 
of proteins in the SDS gel under non-reducing conditions are 
not only determined by their molecular weight but also by the 
actual compactness and shape of the proteins. This may ex- 
plain, for example, why wild-type trypsinogen with six inter- 
chain disulfide bonds moves faster in this system than the chy- 
motrypsin trypsin propeptide chimera containing only four in- 
terchain disulfide bridges (Fig. 2). It is not evident, however, 
that why wild-type chymotrypsinogen moves faster in the SDS 
polyacrylamide gel, than the chymotrypsin trypsin propeptide 
chimera construction (lanes 4-5 in Fig. 2). This may have some- 
thing to do with differential proteolytic cleavage(s) of the two 
proteins (see below). 
Our interpretation of the gel electrophoretic patterns as to 
the different expression levels are concerned was supported by 
direct enzyme activity measurements of the same yeast culture 
media (Table 1). Yeast culture media with the highest concen- 
tration of expressed proteins, wild-type chymotrypsinogen, the 
chymotrypsin trypsin propeptide chimera and wild-type tryp- 
sinogen (lanes 4-6 in Fig. 2) were found to exhibit the largest 
protease activities after specific zymogen activation (Table 1). 
The comparison of the chymotrypsin activities in culture media 
before and after activation showed that almost 100% of the 
Cys 1 Ser-Cys 122Ala and Cys 1 Ser-Cys 122Ser chymotrypsino- 
gen mutants were present in active form, in contrast to the 
l-2% active protease in the wild-type chymotrypsinogen ex- 
pressing culture. This ratio was even lower in cultures express- 
ing the chymotrypsin trypsin chimera zymogen and wild-type 
trypsinogen (Table 1). 
To chemically characterize the non-specifically activated 
forms of chymotrypsinogen mutants CyslSer-Cys122Ala and 
CyslSer-Cys122Ser as well as Cysl22Ser chymotrypsin re- 
leased by enterokinase from the chymotrypsin trypsin propep- 
tide chimera, they were purified to homogeneity (see section 2) 
and subjected to amino acid sequence analysis up to the first 
five N-terminal amino acid residues. The analyses revealed the 
presence of two major N-termini in all three preparations, Ile16 
that is usually formed by the specific activation procedure and 
Asn147 (and, in a smaller amount, Leu149) that may result 
from the autocatalysis of chymotrypsin/ogen [17,18]. In a 
smaller ratio two further N-termini corresponding to residues 
115 (Ser) and 131 (Pro) were also detected. These latter ones 
may be due to further self cleavages of chymotrypsin. Thus, 
N-terminal sequence analysis of the purified chymotrypsin mu- 
tants provided evidence that their structures do not, at least 
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Fig. 2. The expression of the cloned wild-type and mutant enzymes in 
yeast culture medium analyzed by SDS polyacrylamide gel electropho- 
resis in the absence of reducing agents. Purified dl-15,Cysl22Ser 
chymotrypsin (l), CyslSer,Cysl22Ala chymotrypsinogen (2), 
CyslSerCysl22Ser chymotrypsinogen (3), wild-type chymotrypsino- 
gen (4), chymotrypsin trypsin propeptide chimera chymotrypsinogen 
(5), wild-type trypsinogen (6). 
significantly, depend on the activation procedure, and that all 
these preparations are devoid of the propeptide cleaved off. 
Wild-type chymotrypsin, wild-type trypsin and the two chy- 
motrypsin mutants were purified to homogeneity and their 
enzyme activities were determined on a series of amide sub- 
strates. Their kinetic parameters are presented in Table 2. The 
data show that the chymotrypsin mutants formed by either 
non-specific (NS) or enterokinase (E) activation exhibit activi- 
ties undistinguishable from each other and from those of wild- 
type chymotrypsin produced from the zymogen by trypsin acti- 
vation (T) (Table 2). The enterokinase (E) and the non-specifi- 
cally (NS) activated forms, being not contaminated with any 
trypsin, allowed a precise measurement of the intrinsic tryptic 
activity of chymotrypsin (Table 2A). 
4. Discussion 
Proteolytic enzymes are expressed as zymogens with an N- 
terminal propeptide sequence of different length. The propep- 
tides maintain the enzymes in their inactive form until they 
reach the physiological compartment where their activity is 
required. Additionally, some longer propeptides are necessary 
for the correct protein folding (e.g. subtilisin E and a-lytic 
protease [19]). The relatively short propeptides in trypsinogen 
141 
and chymotrypsinogen apparently have only the former func- 
tion. The activation of these zymogens is triggered by the pro- 
teolytic cleavage between the 15th and 16th amino acids [2,3] 
(see Fig. 1). Activation of trypsinogen by specific cleavage of 
enterokinase occurs via a five amino acid long recognition 
sequence, not recognized by other proteases. Thus the trypsin- 
ogen propeptide, though it has a completely disordered confor- 
mation [4-61, effectively prevents premature activation. In con- 
trast, in chymotrypsinogen, the Argl5Leul6 sequence is a 
very typical cleavage site that can be recognized by many pro- 
teases other than trypsin (such as Kex2, a membrane-bound 
protease in yeast that preferentially cleaves arginyl bonds [20]). 
However, the reduction of the propeptide mobility can also be 
an alternative to avoid non-specific activation. Indeed, with the 
exception of residues 11-13, the chymotrypsinogen propeptide 
has a well-defined conformation [7-9,211 stabilized by five H- 
bonding interactions and more importantly by the Cysl- 
Cys122 disulfide bond. 
Our results support the view that the sterically restricted 
structure of the activation site in chymotrypsinogen rather than 
the propeptide sequence itself is the major factor that prevents 
premature activation of the zymogen. We have shown that the 
elimination of the Cysl-Cys122 disulfide bond completely un- 
protects chymotrypsinogen from non-specific activation in the 
yeast expression system. As to the nature of the proteases( 
responsible for non-specific activation, we suppose that in- 
volvement of trypsin like enzyme(s) which is (are) non-secretory 
(e.g. bound to the yeast cell membrane - see above), because 
no significant trypsin-like (and chymotrypsin-like) activity was 
detected in the culture medium of non-transformed yeast 
(Table 1). However, the quite unlikely possibility can not be 
completely excluded either, that a very low intrinsic trypsin-like 
activity of the chymotrypsinogen mutants without disulfide 
bridge l-l 22 causes the non-specific self cleavage of these con- 
structs at the ArglS-Ile16 peptide bond. 
It has been shown that the activelzymogen ratio is more than 
ten-fold lower in the cultures expressing trypsinogen than the 
ones expressing chymotrypsinogen (Table l), suggesting that 
the trypsinogen propeptide is a more potent inactivator of the 
zymogen. This property of the trypsinogen propeptide has been 
successfully transferred to chymotrypsinogen by replacing the 
chymotrypsinogen propeptide with the trypsinogen one. Signif- 
icantly, the expression level of this chymotrypsin trypsin 
propeptide chimera is about 10 times higher than that of wild- 
type chymotrypsinogen (Table 1). Since the catalytic properties 
and the substrate specificity of dl-lS,Cysl22Ser chymotrypsin, 
Table 1 
Chymotrypsin or trypsin activities of the yeast culture media containing different chymotrypsinogen mutants, wild-type chymotrypsinogen and 
trypsinogen expressed 
Expressed protein Activity in 100 ~1 medium (LIOD,,,, ,min-‘) Ratio (%) 
Before activation After activation 
ClS,C122A chymotrypsinogen 0.0527 0.0571 91.20 
ClS,C122S chymotrypsinogen 0.0400 0.0452 89.60 
Wild-type chymotrypsinogen 0.0034 0.2512 1.35 
Chymotrypsin-trypsin propeptide chimera 0.0022 1.6050 0.14 
Wild-type trypsin < 0.0001 0.0810 < 0.12 
Culture medium+ 0.0002 0.0003 
Culture mediums 0.0000 0.0002 _ 
+ Chymotrypsin activity. 
‘Trypsin activity. 
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Kinetic constants determined by the hydrolysis rates of fluorogenic (A) and photometric (B) substrates 
Table 2A 
Enzyme Xaa = Activities on Succinyl-AlaAlaProXaa-AMC 
Leu Tyr Phe Lys 
Wild-type chymotrypsin (T) kc,, 
K, 
&/Km 
Al-15,Cl22A chymotrypsin (NS) k,,, 
K, 
k,,,& 
Al-15,Cl22S chymotrypsin (NS) kc,, 
K, 
&,I& 
Al-15,Cl22S chymotrypsin (E) k,,, 
K, 
k,,,lK, 
Wild-type trypsin 
8.8 x IO2 
3.2 x 10’ 
2.7 x 10’ 
5.3 x 10’ 
2.5 x IO’ 
2.1 x 10’ 
4.8 x 10’ 
3.3 x 10’ 
1.5 x 10’ 
5.2 x lo2 
4.7 x 10’ 
1.1 x 10’ 
6.3 x lo3 
1.2 x 10’ 
5.3 x 10’ 
6.7 x 10’ 
1.6 x 10’ 
4.3 x IO2 
6.7 x l@ 
1.6x 10’ 
4.3 x lo? 
7.1 x 103 
1.1 x 10’ 
6.5 x 10’ 
5.9 x lo3 
2.2 x 10’ 
2.7 x 10’ 
7.2 x 10’ 
2.0 x 10’ 
3.6 x lo2 
6.2 x lo3 
2.3 x 10’ 
2.6 x lo2 
5.3 x 10) 
2.2 x 10’ 
2.4 x 10’ 
2.2 x 10” 
1.6 x lo2 
1.4 x 1om2 
_ 
1.6 x 10’ 
2.2 x lo2 
7.5 x lo-3 
3.7 x loo 
1.9 x lo2 
1.9 x lo-* 
4.8 x 10” 
2.2 x lo2 
2.1 x 1o-2 
2.3 x lo3 
5.7 x 10-l 
3.8 x 103 
kc,,, s-‘; K,,,, ,uM; k,,,lK, s-‘,@M-‘. 
The zymogen activation was made by TPCK-treated trypsin (T), highly purified enterokinase (K) or was non-specific (NS using no activator enzyme 
_ see the text). The values of 3-5 measurements were averaged 
References 
Table 2B 
Enzyme Activities on 
Succ.AAPF-pNA L-Tyr-pNA 
Wild-type 
chymotrypsin (T) kc,, 5.9 x 10’ 6.1 x 10’ 
K, 3.1 x 10’ 4.9 x 10’ 
k,,,lK, 1.9 x lo2 1.3 x IO2 
Al-15,C122A 
chymotrypsin (NS) k,,, 5.0 x lo3 3.7 x 10) 
K, 3.0 x 10’ 3.6 x 10’ 
k,,,lK, 1.7 x IO-’ 1.0 x lo2 
Al-15,Cl22S 
chymotrypsin (NS) kc,, 5.0 x 10’ 2.8 x 10’ 
Kill 4.3 x 10’ 2.7 x 10’ 
k,,,lK,,, 1.9 x 1 O2 1.0x 10’ 
dl~l5,C122S 
chymotrypsin (E) k,,, 4.7 x IO3 4.7 x 10’ 
K, 6.5 x 10’ 3.8 x 10’ 
k,,,lK,,, 7.2 x 10’ 1.2 x lo2 
kc,,, s-l; Km, ,uM; k,,,lK, s-’ .pM-‘. 
The zymogen activation was made by TPCK-treated trypsin (T), highly 
purified enterokinase (K) or was non-specific (NS ~ using no activator 
enzyme see the text). The values of 3-5 measurements were averaged. 
that is the active form of the chymotrypsin trypsin chimera, are 
identical to these of the wild-type chymotrypsin (Table 2), fur- 
ther structure-activity studies on chymotrypsin are carried out 
by mutating and expressing the chymotrypsin trypsin propep- 
tide chimera construct described in this paper. 
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